🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11582+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11582 recruiting trials

Phase 2RecruitingNCT06730308

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

🏥 Sun Yat-sen University📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06813508

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

👨‍⚕️ Fabio Piscaglia, Prof, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06683846

Ivonescimab in the Treatment of Multiple Advanced Tumors

👨‍⚕️ Hongxia Wang, Doctor, Fudan University📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT07254754

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

👨‍⚕️ Mariana Bastos-Oreiro, Hospital General Universitario Gregorio Marañón📍 15 sites📅 Started Nov 2024View details ↗
NAEnrolling by InvitationNCT06863909

Study on the Effectiveness of Journaling as an add-on to Cognitive Behavioral Therapy

👨‍⚕️ Ann-Christine Ehlis, Dr., University Hospital Tübingen Department of Psychiatry and Psychotherapy📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06734637

Efficacy and Safety of Peginterferon in ET and PV.

👨‍⚕️ ZhenYa Hong, Ph.D, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06624189

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

👨‍⚕️ Saul Blecker, NYU Langone Health📍 1 site📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06439485

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion

👨‍⚕️ Sunyoung Lee, MD,PHD, M.D. Anderson Cancer Center📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06569680

Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma

👨‍⚕️ Izidore Lossos, MD, University of Miami📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06578247

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

👨‍⚕️ Global Clinical Leader, Daiichi Sankyo📍 292 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06872333

Allo HSCT for High Risk Hemoglobinopathies

🏥 Masonic Cancer Center, University of Minnesota📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT07085221

Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock

🏥 Renmin Hospital of Wuhan University📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06443502

A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis

👨‍⚕️ Study Director, Takeda📍 14 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06740526

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

🏥 Otsuka Pharmaceutical Development & Commercialization, Inc.📍 5 sites📅 Started Nov 2024View details ↗
Phase 2, PHASE3RecruitingNCT06988475

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

👨‍⚕️ Matthew Krebs, Dr, The Christie Hospital📍 17 sites📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06594445

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

🏥 Masonic Cancer Center, University of Minnesota📍 1 site📅 Started Nov 2024View details ↗
Phase 3Enrolling by InvitationNCT06435312

An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

👨‍⚕️ UCB Cares, 001 844 599 2273 (UCB)📍 7 sites📅 Started Nov 2024View details ↗
RecruitingNCT06983132

Natural History of Familial Cerebral Cavernous Malformations: the CCM_Italia Cohort Study

🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 6 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT07514936

Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

👨‍⚕️ Dahong Liu, Doctor, Chinese PLA General Hospital📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06696274

Kinesiophobia, Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients

👨‍⚕️ Yusuf Topal, Kirsehir Ahi Evran University📍 1 site📅 Started Nov 2024View details ↗
← PreviousPage 203 of 580Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →